Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Datasets Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: GRM010
MIFTS: 34

Germ Cells Tumors

Categories: Cancer diseases, Rare diseases
Tissues Related diseases Publications Drugs
Sources

Aliases & Classifications for Germ Cells Tumors

About this section

MalaCards integrated aliases for Germ Cells Tumors:

Name: Germ Cells Tumors 52
Germ Cell Tumor 58 29 17 71

Classifications:

MalaCards categories:
Global: Rare diseases Cancer diseases
See all MalaCards categories (disease lists)


External Ids:

UMLS via Orphanet 72 C0740345
Orphanet 58 ORPHA3399
UMLS 71 C0205851
Sources

Summaries for Germ Cells Tumors

About this section
MalaCards based summary : Germ Cells Tumors, also known as germ cell tumor, is related to testicular germ cell tumor and nonseminomatous germ cell tumor. The drugs Fentanyl and Sargramostim have been mentioned in the context of this disorder. Affiliated tissues include testis, brain and ovary.

Wikipedia : 74 A germ-cell tumor (GCT) is a neoplasm derived from germ cells. Germ-cell tumors can be cancerous or... more...

Sources

Related Diseases for Germ Cells Tumors

About this section

Diseases related to Germ Cells Tumors via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 624)
# Related Disease Score Top Affiliating Genes
1 testicular germ cell tumor 13.0
2 nonseminomatous germ cell tumor 12.8
3 testicular germ cell tumor 1 12.6
4 childhood central nervous system mixed germ cell tumor 12.6
5 central nervous system germ cell tumor 12.6
6 mixed germ cell tumor 12.5
7 extragonadal nonseminomatous germ cell tumor 12.5
8 adult central nervous system mixed germ cell tumor 12.5
9 pediatric ovarian germ cell tumor 12.5
10 testicular germ cell tumor non-seminomatous 12.5
11 pediatric testicular germ cell tumor 12.5
12 ovarian germ cell cancer 12.5
13 gonadal germ cell tumor 12.5
14 malignant gastric germ cell tumor 12.4
15 malignant cardiac germ cell tumor 12.4
16 ovarian primitive germ cell tumor 12.4
17 testicular pure germ cell tumor 12.4
18 central nervous system adult germ cell tumor 12.4
19 childhood testicular mixed germ cell tumor 12.4
20 primary germ cell tumor of central nervous system 12.4
21 mixed germ cell tumor of central nervous system 12.4
22 malignant germ cell tumor of the cervix uteri 12.4
23 central nervous system childhood germ cell tumor 12.3
24 malignant non-dysgerminomatous germ cell tumor of ovary 12.3
25 malignant germ cell tumor of the vagina 12.3
26 malignant germ cell tumor of the corpus uteri 12.3
27 extragonadal non-dysgerminomatous germ cell tumor 12.3
28 malignant dysgerminomatous germ cell tumor of the ovary 12.3
29 testicular seminoma 12.3
30 testicular cancer 12.2
31 ovarian mixed germ cell neoplasm 12.2
32 testicular germ cell cancer 12.0
33 malignant pineal area germ cell neoplasm 12.0
34 extragonadal germ cell cancer 12.0
35 germ cell cancer 11.9
36 pediatric germ cell cancer 11.9
37 embryonal carcinoma 11.9
38 endodermal sinus tumor 11.8
39 retroperitoneal germ cell neoplasm 11.8
40 teratocarcinoma 11.8
41 seminoma 11.8
42 choriocarcinoma 11.7
43 polyembryoma 11.7
44 germinoma 11.7
45 dysgerminoma 11.7
46 mixed germ cell cancer 11.6
47 spermatocytoma 11.6
48 ovarian endodermal sinus tumor 11.5
49 non-gestational ovarian choriocarcinoma 11.5
50 malignant childhood germ cell neoplasm 11.5

Graphical network of the top 20 diseases related to Germ Cells Tumors:



Diseases related to Germ Cells Tumors
Sources

Symptoms & Phenotypes for Germ Cells Tumors

About this section
Sources

Drugs & Therapeutics for Germ Cells Tumors

About this section

Drugs for Germ Cells Tumors (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 331)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
2
Sargramostim Approved, Investigational Phase 3 83869-56-1, 123774-72-1
3
Ofloxacin Approved Phase 3 82419-36-1 4583
4
Levofloxacin Approved, Investigational Phase 3 100986-85-4 149096
5
Captopril Approved Phase 3 62571-86-2 44093
6
Granisetron Approved, Investigational Phase 3 109889-09-0 3510
7
Fluconazole Approved, Investigational Phase 3 86386-73-4 3365
8
Miconazole Approved, Investigational, Vet_approved Phase 3 22916-47-8 4189
9
Itraconazole Approved, Investigational Phase 3 84625-61-6 55283
10
Palivizumab Approved, Investigational Phase 3 188039-54-5
11
Ribavirin Approved Phase 3 36791-04-5 37542
12
Ondansetron Approved Phase 3 99614-02-5 4595
13
Acyclovir Approved Phase 3 59277-89-3 2022
14
Caspofungin Approved Phase 3 179463-17-3, 162808-62-0 468682 2826718
15
Donepezil Approved Phase 3 120014-06-4 3152
16
Amphotericin B Approved, Investigational Phase 3 1397-89-3 14956 5280965
17
Paclitaxel Approved, Vet_approved Phase 3 33069-62-4 36314
18
Lenograstim Approved, Investigational Phase 3 135968-09-1
19
Etoposide Approved Phase 3 33419-42-0 36462
20
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 3 1177-87-3
21
Dexamethasone Approved, Investigational, Vet_approved Phase 3 50-02-2 5743
22
Mesna Approved, Investigational Phase 3 3375-50-6 598
23
Diphenhydramine Approved, Investigational Phase 3 58-73-1, 147-24-0 3100
24
Promethazine Approved, Investigational Phase 3 60-87-7 4927
25
Cisplatin Approved Phase 3 15663-27-1 84093 441203 2767
26
Bleomycin Approved, Investigational Phase 3 11056-06-7 5360373
27
Mechlorethamine Approved, Investigational Phase 3 51-75-2 4033
28
Ifosfamide Approved Phase 3 3778-73-2 3690
29
Histamine Approved, Investigational Phase 3 51-45-6 774
30
Cyproheptadine Approved Phase 3 129-03-3 2913
31
Vinblastine Approved Phase 3 865-21-4 13342 241903
32
Norgestimate Approved, Investigational Phase 3 35189-28-7 6540478
33
Polyestradiol phosphate Approved Phase 3 28014-46-2
34
Ethinyl Estradiol Approved Phase 3 57-63-6 5991
35
Moxifloxacin Approved, Investigational Phase 3 354812-41-2, 151096-09-2 152946
36
Estradiol Approved, Investigational, Vet_approved Phase 3 50-28-2 5757
37
Mycophenolic acid Approved Phase 3 24280-93-1 446541
38
Dehydroepiandrosterone Approved, Investigational, Nutraceutical Phase 3 53-43-0 9860744
39 Pancreatic Polypeptide Investigational Phase 3 59763-91-6
40 Gastrointestinal Agents Phase 3
41 Liver Extracts Phase 3
42 Hormone Antagonists Phase 3
43 Autonomic Agents Phase 3
44 Cola Phase 3
45 Narcotics Phase 3
46 Anesthetics Phase 3
47 Analgesics Phase 3
48 Analgesics, Opioid Phase 3
49 Anesthetics, General Phase 3
50 Adjuvants, Anesthesia Phase 3

Interventional clinical trials:

(show top 50) (show all 294)
# Name Status NCT ID Phase Drugs
1 Randomized Double-Blind Controlled Phase III Trial of Hyperbaric Oxygen Therapy in Patients Suffering Long-Term Adverse Effects of Radiotherapy for Pelvic Cancer (HOT II) Unknown status NCT01087268 Phase 3
2 A Risk-Adapted Strategy of the Use of Dose-Dense Chemotherapy in Patients With Poor-Prognosis Disseminated Non-Seminomatous Germ Cell Tumors Unknown status NCT00104676 Phase 3 cisplatin;etoposide;ifosfamide;oxaliplatin;paclitaxel
3 Protocol for the Treatment of Extracranial Germ Cell Tumours in Children and Adolescents (GC III) Unknown status NCT00274950 Phase 3 carboplatin;cisplatin;etoposide;ifosfamide;vinblastine sulfate
4 Phase II Prospective Study of Sequential Myeloablative Chemotherapy With Stem Cell Rescue for the Treatment of Selected High Risk CNS Tumors and Recurrent CNS Tumors Unknown status NCT00179803 Phase 2, Phase 3
5 Trial of Imaging and Schedule in Seminoma Testis Unknown status NCT00589537 Phase 3
6 INTERNATIONAL RANDOMIZED STUDY FOR THE SALVAGE TREATMENT OF GERM CELL TUMOURS Unknown status NCT00002566 Phase 3 carboplatin;cisplatin;cyclophosphamide;etoposide;ifosfamide;vinblastine sulfate
7 Randomized Phase II/III Study of Taxol/Paclitaxel-BEP Versus BEP in Patients With Intermediate Prognosis Germ Cell Cancer Unknown status NCT00003643 Phase 2, Phase 3 cisplatin;etoposide;paclitaxel
8 A Study to Investigate the Efficacy and Tolerability of Two Dose Levels of Lerisetron Compared With Granisetron in Patients Receiving Radiotherapy for Stage I Seminoma Unknown status NCT00004219 Phase 3 granisetron hydrochloride;lerisetron
9 A Randomized Phase III Study of Sodium Thiosulfate for the Prevention of Cisplatin-Induced Ototoxicity in Children Completed NCT00716976 Phase 3 sodium thiosulfate
10 A Randomized, Prospective Double-Blind, Placebo-Controlled Trial of Prophylactic Oral Levofloxacin Following Chemotherapy for Lymphoma and Solid Tumors Completed NCT00005590 Phase 3 levofloxacin
11 Radiotherapy Alone Versus Chemotherapy Followed By Response-Based Radiotherapy For Newly Diagnosed Primary CNS Germinoma Completed NCT00085098 Phase 3 carboplatin;cisplatin;cyclophosphamide;etoposide
12 Carboplatin in the Adjuvant Treatment of Stage I Seminoma: A Radomized Comparison of Single Agent Carboplatin With Radiotherapy in the Adjuvant Treatment of Stage I Seminoma of the Testis, Following Orchidectomy Completed NCT00003014 Phase 3 carboplatin
13 RANDOMIZED MULTIINSTITUTIONAL PHASE III TRIAL OF BEP AND HIGH DOSE CHEMOTHERAPY VERSUS BEP ALONE IN PREVIOUSLY UNTREATED PATIENTS WITH POOR RISK GERM CELL TUMORS Completed NCT00002596 Phase 3 carboplatin;cisplatin;cyclophosphamide;etoposide
14 SIOP Intracranial Germ Cell Tumours Protocol Completed NCT00293358 Phase 3 carboplatin;cisplatin;etoposide phosphate;ifosfamide
15 Phase III Study of Captopril in Patients Undergoing Autologous Bone Marrow/Stem Cell Transplantation Completed NCT00004230 Phase 3 captopril;cyclophosphamide
16 A Randomized, Comparative Study of Itraconazole Versus Fluconazole for Prevention of Aspergillus Infections in Peripheral Blood Stem Cell and Marrow Transplant Recipients Completed NCT00003883 Phase 3 fluconazole;itraconazole
17 A Randomized Double-Blind Placebo-Controlled Phase III Study To Evaluate The Safety And Efficacy Of Palivizumab Combined With Aerosolized Ribavirin Compared To Ribavirin Alone To Treat RSV Pneumonia In Patients With Bone Marrow Transplants (BMT) Completed NCT00014391 Phase 3 ribavirin
18 A Randomized Phase III Study of Sequential High-Dose Cisplatinum/Etoposide/Ifosfamide Plus Stem Cell Support Versus BEP in Patients With Poor Prognosis Germ Cell Cancer Completed NCT00003941 Phase 3 cisplatin;etoposide;ifosfamide
19 Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy Completed NCT01346267 Phase 3
20 Music Video and Adolescent/Young Adult Resilience During Transplant Completed NCT00305851 Phase 3
21 A Phase III Multicenter Study of Cytomegalovirus Prophylaxis With Valacyclovir for the Prevention of Serious Fungal and Bacterial Infections Among Cytomegalovirus Seronegative Recipients of Cytomegalovirus Seropositive Sx Stem Cell Transplants Completed NCT00045292 Phase 3 acyclovir;acyclovir sodium;valacyclovir
22 A Randomized, Double-blind, Placebo-controlled Multi-center Study to Evaluate the Safety and Efficacy of Fentanyl Sublingual Spray (Fentanyl SL Spray) for the Treatment of Breakthrough Cancer Pain Completed NCT00538850 Phase 3 Fentanyl sublingual spray;Placebo
23 A Strategic Study to Determine the Optimal Moment to Initiate Systemic Antifungal Therapy With Ambisome in Granulocytopenic Cancer Patients With Unexplained Fever Refractory to Empirical Antibacterials Completed NCT00003938 Phase 3 liposomal amphotericin B
24 A Multicenter, Double-Blind, Randomized, Comparative Study To Evaluate The Safety, Tolerability, And Efficacy Of MK-0991 Versus (Amphotericin B) Liposome For Injection As Empirical Therapy In Patients With Persistent Fever And Neutropenia Completed NCT00008359 Phase 3 caspofungin acetate;liposomal amphotericin B
25 Phase III Double Blind, Placebo Controlled Study of Donepezil in the Irradiated Brain Completed NCT00369785 Phase 3 donepezil hydrochloride;Placebo
26 A Randomized Phase III Toxicity Study of Day 2, 3, 8, 15 Short (30 Minute) Versus Day 1, 2, 3 Long (72 Hours) Infusion Bleomycin for Patients With IGCCCG Good Prognosis Germ Cell Tumors, TE3 Completed NCT00324298 Phase 3 cisplatin;etoposide
27 Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial Completed NCT01376349 Phase 3 prasterone
28 HSCT-CHESS to Enhance Hematopoietic Transplant Recovery Completed NCT00782145 Phase 3
29 A Multicenter, Prospective, Randomized Trial Comparing Paclitaxel and Carboplatin or Bleomycin, Etoposide and Cisplatin in the Treatment of Malignant Ovarian Germ Cell Tumors Recruiting NCT02429687 Phase 3 Paclitaxel;Carboplatin;Bleomycin;Etoposide;Cisplatin
30 A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients With Germ Cell Tumors Recruiting NCT03067181 Phase 3 Bleomycin;Carboplatin;Cisplatin;Etoposide;Etoposide Phosphate
31 A Randomized Phase III Trial Comparing Conventional-Dose Chemotherapy Using Paclitaxel, Ifosfamide, and Cisplatin (TIP) With High-Dose Chemotherapy Using Mobilizing Paclitaxel Plus Ifosfamide Followed by High-Dose Carboplatin and Etoposide (TI-CE) as First Salvage Treatment in Relapsed or Refractory Germ Cell Tumors Recruiting NCT02375204 Phase 3 paclitaxel;ifosfamide;cisplatin;pegylated G-CSF;G-CSF;carboplatin;etoposide phosphate
32 Phase 3 Accelerated BEP: A Randomised Phase 3 Trial of Accelerated Versus Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours Recruiting NCT02582697 Phase 3 Bleomycin (active name: Bleomycin Sulfate);Etoposide;Cisplatin;Pegylated G-CSF (Pegfilgrastim);Filgrastim
33 A Single Group Trial Evaluating One Cycle of Adjuvant BEP Chemotherapy in High Risk, Stage 1 Non-seminomatous Germ Cell Tumours of the Testis (NSGCTT) Active, not recruiting NCT01726374 Phase 3 BEP(500)
34 Prevention of Cancer/Treatment-Related Weight Loss in Children at High Nutritional Risk Terminated NCT01132547 Phase 3 cyproheptadine hydrochloride
35 A Randomized Phase III Study of Paclitaxel, Ifosfamide and Cisplatin Versus Vinblastine, Ifosfamide and Cisplatin as Second-Line Therapy for Patients With Relapsed/Resistant Germ Cell Tumors Terminated NCT00072215 Phase 3 cisplatin;ifosfamide;paclitaxel;vinblastine
36 Randomized, Double Blinded, Placebo-Controlled Trial of Antibacterial Prophylaxis for the Prevention of Bacterial Infections in the Post-Engraftment Phase After Allogeneic Hematopoeitic Stem Cell Transplantation Terminated NCT00324324 Phase 3 moxifloxacin hydrochloride;Placebo
37 A Randomized Study to Evaluate The Efficacy of Mycophenolate Mofetil Added to The Systemic Immunosuppressive Regimen First Used For Treatment of Chronic Graft-Versus-Host Disease Terminated NCT00089141 Phase 3 mycophenolate mofetil;placebo
38 Phase I/II Multicentre Trial of Salvage Chemotherapy With Gem-TIP for Relapsed Germ Cell Cancer Unknown status NCT00551122 Phase 1, Phase 2 cisplatin;gemcitabine hydrochloride;ifosfamide;paclitaxel
39 Tandem High-Dose Chemotherapy (HDCT) With Peripheral-Blood Stem-Cell Rescue for Patients With Metastatic Germ-Cell Tumors Failing First-Line Treatment Unknown status NCT01172912 Phase 2 carboplatin;cisplatin;dexamethasone;etoposide;ifosfamide
40 A Phase IIA Trial of Continuous Five Day Infusions of MSI-1256F (Squalamine Lactate) Plus Carboplatin for Therapy of Refractory and Resistant Stage III and IV Ovarian Cancer Unknown status NCT00021385 Phase 2 carboplatin;squalamine lactate
41 A Prospective Multicenter Phase II Trial of Gemcitabine, Cisplatin, and Ifosfamide (GIP) in Patients With Relapsed Non-Seminomatous Germ-Cell Tumors (NSGCT) and a Predicted Favorable Prognosis Unknown status NCT00127049 Phase 2 gemcitabine, ifosfamide, cisplatin, G-CSF
42 Open-label, Multicenter, Phase I/II Trial to Evaluate Efficacy Safety of the Combination Therapy of Genexol-PM and Carboplatin as a Firstline Treatment in Subjects With Advanced Ovarian Cancer Unknown status NCT00886717 Phase 1, Phase 2 carboplatin;paclitaxel-loaded polymeric micelle
43 A Phase I-II Trial of Mild Whole-Body Hyperthermia Combined With Liposomal Doxorubicin/5-Fluorouracil in Patients With Advanced Malignancy Unknown status NCT00003135 Phase 2 fluorouracil;pegylated liposomal doxorubicin hydrochloride
44 Clinical Correlative Studies In Primary Central Nervous System Germ Cell Tumors: The Third International CNS Germ Cell Tumor Study Group Protocol Unknown status NCT00025324 Phase 2 carboplatin;cyclophosphamide;etoposide;thiotepa
45 Systematic Nutritional Care in Patients Receiving First-line Chemotherapy for Metastatic Gynecologic Cancer in a Phase II Study Unknown status NCT00905658 Phase 2
46 A Multiinstitutional Trial To Evaluate The Prophylactic Use Of NASA-Developed Light Emitting Diodes For The Prevention Of Oral Mucositis In Bone Marrow Transplant Patients Unknown status NCT00036712 Phase 2
47 Phase II Trial of Paclitaxel, Ifosfamide, and Cisplatin in Previously Untreated Intermediate and Poor Risk Germ Cell Tumor Patients Completed NCT00470366 Phase 2 cisplatin;ifosfamide;paclitaxel
48 High-Dose Thiotepa With Autologous Stem Cell Rescue in Patients With Malignancies Refractory to Conventional Chemotherapy Completed NCT00003173 Phase 2 thiotepa
49 A Phase II Study of BMS-247550 In Advanced Germ Cell Tumor Patients - THERAPEUTIC/DIAGNOSTIC PROTOCOL Completed NCT00070096 Phase 2 ixabepilone
50 Randomized Phase II-Trial to Determine the Impact of Darbepoetin Alfa on the Frequency of RBC Transfusions in Patients With Metastatic "Poor Prognosis" Germ Cell Tumor Treated With High-Dose Chemotherapy (HD-VIP Regimen) Completed NCT00204633 Phase 2 Darbepoetin alfa

Search NIH Clinical Center for Germ Cells Tumors

Sources

Genetic Tests for Germ Cells Tumors

About this section

Genetic tests related to Germ Cells Tumors:

# Genetic test Affiliating Genes
1 Germ Cell Tumor 29
Sources

Anatomical Context for Germ Cells Tumors

About this section

MalaCards organs/tissues related to Germ Cells Tumors:

40
Testis, Brain, Ovary, Lymph Node, Bone, Bone Marrow, Pineal
Sources

Publications for Germ Cells Tumors

About this section

Articles related to Germ Cells Tumors:

(show top 50) (show all 3520)
# Title Authors PMID Year
1
Bilateral wunderlich syndrome secondary to synchronous bilateral testicular germ cell tumor. A case report. 61
31641608 2020
2
Management and outcomes of ruptured, perforated or fistulized tumors of mesenchymal origin. 61
31846095 2019
3
Pure germinoma occurring 11 years after total pineal mature teratoma removal: a case report and review of the literature. 61
31385089 2019
4
Granulocytic sarcoma and mediastinal germ cell tumor: A common cell of origin? 61
29913128 2019
5
Adult-Onset Mixed Germ Cell Tumor Composed Mainly of Yolk Sac Tumor Around the Pineal Gland: A Case Report and Review of the Literature. 61
31470154 2019
6
Intracranial growing teratoma syndrome observed at 44 months after initial treatment; a case presentation and literature review. 61
31853895 2019
7
Contemporary Assessment of Long-Term Survival Rates in Patients With Stage I Nonseminoma Germ-Cell Tumor of the Testis: Population-Based Comparison Between Surveillance and Active Treatment After Initial Orchiectomy. 61
31515197 2019
8
Interobserver Agreement in Vascular Invasion Scoring and the Added Value of Immunohistochemistry for Vascular Markers to Predict Disease Relapse in Stage I Testicular Nonseminomas. 61
31490238 2019
9
Clinical management of malignant ovarian germ cell tumors: A 26-year experience in a tertiary care institution. 61
31446304 2019
10
18F-Flourodeoxy glucose PET-computed tomography in testicular carcinoma: diagnostic and prognostic value. 61
31568190 2019
11
Integrated clinical, histopathological, and molecular data analysis of 190 central nervous system germ cell tumors from the iGCT Consortium. 61
31420671 2019
12
Derivation of neural stem cells from human teratomas. 61
31733440 2019
13
Identification and Validation Model for Informative Liquid Biopsy-Based microRNA Biomarkers: Insights from Germ Cell Tumor In Vitro, In Vivo and Patient-Derived Data. 61
31847394 2019
14
Asymptomatic azygos vein overflow in a young patient with primary mediastinal seminoma. 61
31568668 2019
15
Large retroperitoneal lymphadenopathy and increased risk of venous thromboembolism in patients receiving first-line chemotherapy for metastatic germ cell tumors: A study by the global germ cell cancer group (G3). 61
31715650 2019
16
The effects of hypogonadism on quality of life in survivors of germ cell tumors treated with surgery alone versus surgery plus platinum-based chemotherapy. 61
31707501 2019
17
Cytologic diagnosis of primary pineal germ cell tumor with a yolk sac component, in cerebrospinal fluid. 61
31785016 2019
18
Classic and "Dissecting" Gonadoblastoma in a Phenotypic Girl With a 46, XX Peripheral Karyotype and No Evidence of a Disorder of Sex Development. 61
30252730 2019
19
Canine Ependymoma: Diagnostic Criteria and Common Pitfalls. 61
31266414 2019
20
Serum MicroRNA-371a-3p Levels Predict Viable Germ Cell Tumor in Chemotherapy-naïve Patients Undergoing Retroperitoneal Lymph Node Dissection. 61
31699528 2019
21
Less nephrotoxicity of paclitaxel and ifosfamide plus nedaplatin for refractory or relapsed germ cell tumors in patients with impaired renal function. 61
31701563 2019
22
Microneurosurgical Removal of a Globus Pallidus Tumor With Cottonoid-Guided Intraoperative Ultrasonography: 2-Dimensional Operative Video. 61
31768549 2019
23
Developing a Highly Specific Biomarker for Germ Cell Malignancies: Plasma miR371 Expression Across the Germ Cell Malignancy Spectrum. 61
31553692 2019
24
Site of extranodal metastasis impacts survival in patients with testicular germ cell tumors. 61
31355922 2019
25
Association Between Marijuana Use and Risk of Cancer: A Systematic Review and Meta-analysis. 61
31774524 2019
26
Differentiation of testicular seminoma and nonseminomatous germ cell tumor on magnetic resonance imaging. 61
31702681 2019
27
Unusual intrascrotal lesions in adults in urological practice. 61
31697257 2019
28
Predictors of Loss to Follow-Up Among Pediatric and Adult Hematopoietic Cell Transplantation Survivors: A Report from the Center for International Blood and Marrow Transplant Research. 61
31726205 2019
29
Mixed-type primary germ cell tumor of the mediastinum in a young adult male with a sudden life threatening condition: A case report. 61
31693305 2019
30
Efficacy and safety of buparlisib, a PI3K inhibitor, in patients with malignancies harboring a PI3K pathway activation: a phase 2, open-label, single-arm study. 61
31741715 2019
31
Rapidly enlarging abdominal mass in a patient with recurrent germ cell tumor. 61
31788307 2019
32
Primary and Recurrent Growing Teratoma Syndrome in Central Nervous System Nongerminomatous Germ Cell Tumors: Case Series and Review of the Literature. 61
31751614 2019
33
Treatment and survival of primary intracranial germ cell tumors: a population-based study using SEER database. 61
31745701 2019
34
Retroperitoneal Lymph Node Dissection as Primary Treatment for Men With Testicular Seminoma: Utilization and Survival Analysis Using the National Cancer Data Base, 2004-2014. 61
31818649 2019
35
The prognostic impact of different tumor marker levels in nonseminomatous germ cell tumor patients with intermediate prognosis: A registry of the International Global Germ Cell Tumor Collaborative Group (G3). 61
31494007 2019
36
Dysgerminoma in a 10-Year Old with 45X/46XY Turner Syndrome Mosaicism. 61
31279777 2019
37
Gonadoblastoma-Associated Mixed Gonadal Germ Cell Tumor with Dysgerminoma and Hepatoid Yolk Sac Tumor Components in 46XY Gonadal Dysgenesis. 61
31175959 2019
38
Yolk Sac Tumors of the Head and Neck in Aicardi Syndrome. 61
31640397 2019
39
[Sexual dysfunctions of patients treated with orchidectmoy, chemotherapy and retroperitoneal lymphadenectomy, need for systematic andrological care?] 61
31126677 2019
40
Experience Profiling of Fluorescence-Guided Surgery II: Non-Glioma Pathologies. 61
31686441 2019
41
Wnt suppressor and stem cell regulator TCF7L1 is a sensitive immunohistochemical marker to differentiate testicular seminoma from non-seminomatous germ cell tumor. 61
31381875 2019
42
An extragonadal yolk sac tumor presumed to be of postmeiotic germ cell origin by genetic zygosity analysis via single nucleotide polymorphism array. 61
31631430 2019
43
Treatment and Outcome of Patients with Stage IS Testicular Cancer: A Retrospective Study from the Spanish Germ Cell Cancer Group. 61
31163007 2019
44
[Management of metastatic testicular germ cell tumors]. 61
31466695 2019
45
Paraneoplastic sensorimotor neuropathy associated with mediastinal germ cell tumor: favorable outcome after high-dose intravenous immunoglobulin therapy. 61
31578653 2019
46
Re: New Insights into Germ Cell Tumor Genomics. 61
31282270 2019
47
Re: Nationwide Patterns of Care for Stage II Nonseminomatous Germ Cell Tumor of the Testicle. 61
31661378 2019
48
[Relapse surveillance of patients with testicular germ cell tumor]. 61
31495441 2019
49
Infantile synchronous primary bilateral testicular germ cell tumor: a case report and review of the literature. 61
31807430 2019
50
High Endogenous DNA Damage Levels Predict Hematological Toxicity in Testicular Germ Cell Tumor Patients Treated With First-Line Chemotherapy. 61
31281064 2019
Sources

Variations for Germ Cells Tumors

About this section
Sources

Expression for Germ Cells Tumors

About this section
Search GEO for disease gene expression data for Germ Cells Tumors.
Sources

Pathways for Germ Cells Tumors

About this section
Sources

GO Terms for Germ Cells Tumors

About this section
Sources

Sources for Germ Cells Tumors

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....